Found 12 matching trials
The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition PHASE4 Chronic utilization of bio-incompatible peritoneal dialysis (PD) solution h...
Show More Location
Department of Medicine & Therapeutics, Prince of Wales Hospital
Learn More & Join Trial
HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma PHASE2 This single-center, prospective proof-of-concept study is designed to evalu...
Show More Location
Carolinas Medical Center
Learn More & Join Trial
Characterization of the Role of Histamine in Children With Asthma PHASE2 Asthma, a chronic disease which produces significant morbidity and mortalit...
Show More Location
Children's Mercy Hospital and Clinics
Learn More & Join Trial
The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis PHASE4 To investigate the biocompatibility of the peritoneal dialysis (PD) solutio...
Show More Location
Centrum Dializ Fresenius Nephrocare
Learn More & Join Trial
Gut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's Disease N/A With the global ageing population, neurodegenerative disorders including sy...
Show More Location
The Chinese University of Hong Kong
Learn More & Join Trial
Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC PHASE4 his multicenter, open-label, single-arm phase I/II trial will evaluate the ...
Show More Location
Guangdong Provincial People's Hospital
Learn More & Join Trial
Comparing Conventional Continuous Ambulatory Peritoneal Dialysis Prescription (C-CAPD) With Modified-CAPD (M-CAPD) Prescription in Children With End-stage Kidney Disease From Low-resource Settings NA This study aims to compare modified CAPD (M-CAPD) and conventional CAPD (C-...
Show More Location
Philippine General Hospital
Learn More & Join Trial
A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205] PHASE2 This is a phase 2 multi-cohort, un-controlled, non-randomized, open-label, ...
Show More Location
Investigational Site Number : 0320005
Learn More & Join Trial
A Study of Isatuximab-based Therapy in Participants With Lymphoma PHASE1 Primary Objectives:
Phase 1
-To characterize the safety and tolerability ...
Show More Location
Investigational Site Number :2500005
Learn More & Join Trial
Study of ATX-01 in Participants With DM1 PHASE1 The goal of this clinical trial is to test ATX-01 in participants with myot...
Show More Learn More & Join Trial